Boomray Pharmaceuticals

OUR VISION

Becoming a world-class innovation technology development and translational platform for radiopharmaceuticals

OUR MISSION

Delivering innovative radiopharmaceuticals to patients around the world

01 02 03
BOOMRAY
BoomRay Pharmaceutical Co., Ltd.
BoomRay Pharmaceutical Co., Ltd. is a clinical-stage biotech focusing on delivering innovative radioactive targeted drugs (RDC) for precise tumor diagnosis and treatment. Currently, BoomRay has multiple clinical-stage RTD products. In 2022, BoomRay completed nearly RMB300 million in Series A financing. At present, BoomRay has a number of proprietary diagnostic and therapeutic radionuclide drugs under research, with independent intellectual property rights. Headquartered in Suzhou, BoomRay has also established business departments for new drug discovery, clinical translations, and registration in Beijing and Shanghai. The company has a management team led by overseas high-profile talents with rich backgrounds in the nuclear medicine industry and experience in drug design and translation. Relying on the technology platforms and basic research infrastructures of Peking University...
BoomRay Pharmaceutical Co., Ltd.
  • Telephone:
    +86-512-6516 5223
  • E-mail:
    info@boomray.com
  • Address:
    Building 7, Yong an Road, SND, Suzhou, Jiangsu, China
    Post code: 215000

Wechat public account
Copyright BoomRay Pharmaceutical Co., Ltd. © All rights reserved 苏ICP备2024090691号-1